Extragastric diseases associated with Helicobacter pylori infection

Current Gastroenterology Reports

Volumn 8, Issue 6, 2006, Pages 458-464

  Goodman, Karen J ^a   Joyce, Stephanie L ^b   Ismond, Kathleen P ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IRON; METRONIDAZOLE;

ATHEROSCLEROSIS; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM DETECTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC OTITIS MEDIA; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; EAR SURGERY; ERADICATION THERAPY; GROWTH RETARDATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFECTION RISK; IRON DEFICIENCY ANEMIA; IRON THERAPY; META ANALYSIS; NONHUMAN; PATHOGENESIS; POPULATION RESEARCH; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; ROSACEA; SYSTEMATIC REVIEW; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT FAILURE; UNITED KINGDOM; URTICARIA;

ANEMIA, IRON-DEFICIENCY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RISK FACTORS; URTICARIA;

EID: 33845873348     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-006-0035-3     Document Type: Review

References (50)

1. Kato S, Sherman PM: What is new related to Helicobacter pylori infection in children and teenagers? Arch Pediatr Adolesc Med 2005, 159:415-421.
2. Sherman PM, Lin FYH: Extradigestive manifestations of Helicobacter pylori infection in children and adolescents. Canadian J Gastroenterol 2005, 19:421-424.
3. Nilsson H-O, Pietroiusti A, Gabrielli M, et al.: Helicobacter pylori and extragastric diseases: other helicobacters. Helicobacter 2005, 10:54-65.
4. Malfertheiner P, Megraud F, O'Morain C: Guidelines for management of Helicobacter pylori infection. Business Briefing: European Gastroenterology Review, 2005. http://www.helicobacter.org. Access date: 7/10/05.
5. Jones NL, Sherman P, Fallone CA, et al.: Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents: an evidence-based evaluation. Can J Gastroenterol 2005, 19:399-408.
6. Danesh J, Peto R: Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998, 316:1130-1132.
7. Danesh J: Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: meta-analyses of prospective studies. Am Heart J 1999, 138:S434-S437.
8. Corrado E, Novo S: Role of inflammation and infection in vascular disease. Acta Chir Belg 2005, 105:567-579.
9. Liuba P, Pesonen E: Infection and early atherosclerosis: Does the evidence support causation? Acta Paediatr 2005, 94:643-651.
10. Elkind MS, Cole JW: Do common infections cause stroke? Semin Neurol 2006, 26:88-99.
11. Kanbay M, Gür G, Yücel M, et al.: Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci 2005, 50:1228-1231.
12. Davi G, Neri M, Falco A, et al.: Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. Arterioscler Thromb Vasc Biol 2005, 25:246-251.
13. Corrado E, Rizzo M, Tantillo R, et al.: Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke 2006, 37:482-486.
14. Sung KC, Rhee EJ, Ryu SH, et al.: Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults. Int J Cardiol 2005, 102:411-417.
15. Shmuely H, Passaro DJ, Vaturi M, et al.: Association of CagA+ Helicobacter pylori infection with aortic atheroma. Atherosclerosis 2005, 179:127-132.
16. Franchini M, Veneri D: Helicobacter pylori-associated immune thrombocytopenia. Platelets 2006, 17:71-77.
17. Fujimura K: Helicobacter pylori infection and idiopathic thrombocytopenic purpura. Int J Hematol 2005, 81:113-118.
18. Jackson S, Beck PL, Pineo GF, et al.: Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature. Am J Hematol 2005, 78:142-150.
19. Bussel JB, Ostrow A, Segal JB: Response to treatment of helicobacter pylori in patients with immune thrombocytopenic purpura: A systematic review and metaanalysis. Blood 2005, 106:2151.
20. Ishiyama M, Teramura M, Iwabe K, et al.: Clonally expanded T-cells in the peripheral blood of patients with idiopathic Thrombocytopenic purpura and Helicobacter pylori infection. Int J Hematol 2006, 83:147-151.
21. Veneri D, De MG, Solero P, et al.: Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment. Platelets 2005, 16:307-311.
22. DuBois S, Kearney DJ: Iron-deficiency anemia and Helicobacter pylori infection: a review of the evidence. Am J Gastroenterol 2005, 100:453-459.
23. Hershko C, Lahad A, Kereth D: Gastropathic sideropenia. Best Pract Res Clin Haematol 2005, 18:363-380.
24. Valiyaveettil AN, Hamide A, Bobby Z, et al.: Effect of anti-Helicobacter pylori therapy on outcome of iron-deficiency anemia: A randomized, controlled study. Indian J Gastroenterol 2005, 24:155-157.
25. Gessner BD, Baggett FIC, Muth PT, et al.: A controlled, household-randomized, open-label trial of the effect that treatment of Helicobacter pylori infection has on iron deficiency in children in rural Alaska. J Infect Dis 2006, 193:537-546.
26. Mahalanabis D, Islam MA, Shaikh S, et al.: Haematological response to iron supplementation is reduced in children with asymptomatic Helicobacter pylori infection. Br J Nutr 2005, 94:969-975.
27. Cardenas VM, Mulla ZD, Ortiz M, et al.: Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol 2006, 163:127-134.
28. Baggett FIC, Parkinson AJ, Muth PT, et al.: Endemic iron deficiency associated with Helicobacter pylori infection among scbool-aged children in Alaska. Pediatrics 2006, 117:e396-e404.
29. Weyermann M, Rothenbacher D, Gayer L, et al.: Role of Helicobacter pylori infection in iron deficiency during pregnancy. Am J Obstetr Gynecol 2005, 192:548-553.
30. Chimonas M, Baggett FIC, Parkinson AJ, et al.: Asymptomatic Helicobacter pylori infection and iron deficiency anemia are not associated with decreased growth among Alaskan Native children aged 7-11 years. Helicobacter 2006, 11:159-167.
31. Sood M, Joshi S, Akobeng A, et al.: Growth in children with Helicobacter pylori infection and dyspepsia. Arch Dis Child 2005, 90:1025-1028.
32. Yang YJ, Shen BS, Lee SC, et al.: Children of Helicobacter pylori-infected dyspeptic mothers are predisposed to H-Pylori acquisition with subsequent iron deficiency and growth retardation. Helicobacter 2005, 10:249-255.
33. Mera RM, Correa P, Fontham FE, et al.: Effects of a new Helicobacter pylori infection on height and weight in Colombian children. Ann Epidemiol 2005, 16:347-351.
34. Moayyedi P, Forman D, Duffett S, et al.: The association between Helicobacter pylori infection and adult height. Eur J Epidemiol 2005, 20:455-465.
35. Agirdir BV, Bozova S, Derin AT, et al.: Chronic otitis media with effusion and Helicobacter pylori. Int J Pediatr Otorhinolaryngol 2006, 70:829-834.
36. Morinaka S, Tominaga M, Nakamura H: Detection of Helicobacter pylori in the middle ear fluid of patients with otitis media with effusion. Otolaryngol Head Neck Surg 2005, 133:791-794.
37. Bitar MA, Soweid A, Mahfouz R, et al.: Is Helicobacter pylori really present in the adenoids of children? Eur Arch Oto-Rhino-Laryngol 2005, 262:987-992.
38. Bitar M, Mahfouz R, Soweid A, et al.: Does Helicobacter pylori colonize the nasopharynx of children and contribute to their middle ear disease? Acta Otolaryngol 2006, 126:154-159.
39. Yilmaz MD, Aktepe O, Cetinkol Y, et al.: Does Helicobacter pylori have role in development of otitis media with effusion? Int J Pediatr Otorhinolaryngol 2005, 69:745-749.
40. Karlidag T, Bulut Y, Keles E, et al.: Detection of Helicobacter pylori in children with otitis media with effusion: A preliminary report. Laryngoscope 2005, 115:1262-1265.
41. Kutluhan A, Yurttas V, Akarca US, et al.: Possible role of Helicobacter pylori in the etiopathogenesis of chronic otitis media. Otol Neurotol 2005, 26:1125-1127.
42. Pitkaranta A, Kolho KL, Rautelin H: Helicobacter pylori in children who are prone to upper respiratory tract infections. Arch Otolaryngol Head Neck Surg 2005, 131:256-258.
43. Yilmaz T, Ceylan M, Akyon Y, et al.: Helicobacter pylori: a possible association with otitis media with effusion. Otolaryngol Head Neck Surg 2006, 134:772-777.
44. Diamantis S, Waldorf HA: Rosacea: clinical presentation and pathophysiology. J Drugs Dermatol 2006, 5:8-12.
45. van Zuuren EJ, Graber MA, Hollis S, et al.: Interventions for rosacea. Cochrane Database Syst Rev 2005, 3: CD003262.
46. Federman DG, Kirsner RS, Moriarty JP, et al.: The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol 2003, 49:861-864.
47. Baskan EB, Türker T, Gülten M, et al.: Lack of correlation between Helicobacter pylori infection and autologous serum skin test in chronic idiopathic urticaria. Int J Dermatol 2005, 44:993-995.
48. Mini R, Figura N, D'Ambrosio C, et al.: Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria. Proteomics 2005, 5:777-787.
49. Greenland S. Basic methods for sensitivity analysis and external adjustment. In Modern Epidemiology. Edited by Rothman K, Greenland S. Philadelphia: Lippencott-Raven; 1998:343-357
50. Phillips CV: The economics of 'more research is needed'. Int J Epidemiol 2001, 30:771-776.